Skip to main content

Table 5 Single dose adults—antibodies (reciprocal dilution)—by time interval

From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals

Categorical time Number of individuals Average time (days) GMT (reciprocal dilution)
PV (5–9 years) 23 2797 (2008–3285) 152
PV (> 10 years) 45 5021 (3650–5475) 100